Literature DB >> 23297128

Sickle hemoglobin disturbs normal coupling among erythrocyte O2 content, glycolysis, and antioxidant capacity.

Stephen C Rogers1, Jerlinda G C Ross, Andre d'Avignon, Lindsey B Gibbons, Vered Gazit, Mojibade N Hassan, Dylan McLaughlin, Sherraine Griffin, Tara Neumayr, Malcolm Debaun, Michael R DeBaun, Allan Doctor.   

Abstract

Energy metabolism in RBCs is characterized by O2-responsive variations in flux through the Embden Meyerhof pathway (EMP) or the hexose monophosphate pathway (HMP). Therefore, the generation of ATP, NADH, and 2,3-DPG (EMP) or NADPH (HMP) shift with RBC O2 content because of competition between deoxyhemoglobin and key EMP enzymes for binding to the cytoplasmic domain of the Band 3 membrane protein (cdB3). Enzyme inactivation by cdB3 sequestration in oxygenated RBCs favors HMP flux and NADPH generation (maximizing glutathione-based antioxidant systems). We tested the hypothesis that sickle hemoglobin disrupts cdB3-based regulatory protein complex assembly, creating vulnerability to oxidative stress. In RBCs from patients with sickle cell anemia, we demonstrate in the present study constrained HMP flux, NADPH, and glutathione recycling and reduced resilience to oxidative stress manifested by membrane protein oxidation and membrane fragility. Using a novel, inverted membrane-on-bead model, we illustrate abnormal (O2-dependent) association of sickle hemoglobin to RBC membrane that interferes with sequestration/inactivation of the EMP enzyme GAPDH. This finding was confirmed by immunofluorescent imaging during RBC O2 loading/unloading. Moreover, selective inhibition of inappropriately dispersed GAPDH rescues antioxidant capacity. Such disturbance of cdB3-based linkage between O2 gradients and RBC metabolism suggests a novel mechanism by which hypoxia may influence the sickle cell anemia phenotype.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23297128      PMCID: PMC3587328          DOI: 10.1182/blood-2012-02-414037

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  45 in total

1.  Regulation of the glycophorin C-protein 4.1 membrane-to-skeleton bridge and evaluation of its contribution to erythrocyte membrane stability.

Authors:  S H Chang; P S Low
Journal:  J Biol Chem       Date:  2001-04-09       Impact factor: 5.157

Review 2.  Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple.

Authors:  F Q Schafer; G R Buettner
Journal:  Free Radic Biol Med       Date:  2001-06-01       Impact factor: 7.376

3.  Cell adhesion onto highly curved surfaces: one-step immobilization of human erythrocyte membranes on silica beads.

Authors:  Stefan Kaufmann; Motomu Tanaka
Journal:  Chemphyschem       Date:  2003-07-14       Impact factor: 3.102

Review 4.  The not-so-simple process of sickle cell vasoocclusion.

Authors:  Stephen H Embury
Journal:  Microcirculation       Date:  2004-03       Impact factor: 2.628

5.  The relationship between red cell 2,3-diphosphoglycerate and levels of hemoglobin in the human.

Authors:  J W Eaton; G J Brewer
Journal:  Proc Natl Acad Sci U S A       Date:  1968-10       Impact factor: 11.205

6.  Quantitation of superoxide generation and substrate utilization by vascular NAD(P)H oxidase.

Authors:  Heraldo P Souza; Xiaoping Liu; Alexandre Samouilov; Periannan Kuppusamy; Francisco R M Laurindo; Jay L Zweier
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-02       Impact factor: 4.733

7.  Quantitation of erythrocyte pentose pathway flux with [2-13C]glucose and 1H NMR analysis of the lactate methyl signal.

Authors:  Teresa C Delgado; M Margarida Castro; Carlos F Geraldes; John G Jones
Journal:  Magn Reson Med       Date:  2004-06       Impact factor: 4.668

Review 8.  Nitric oxide transport in blood: a third gas in the respiratory cycle.

Authors:  Allan Doctor; Jonathan S Stamler
Journal:  Compr Physiol       Date:  2011-01       Impact factor: 9.090

9.  O(2)-dependent stimulation of the pentose phosphate pathway by S-nitrosocysteine in human erythrocytes.

Authors:  Francesco Misiti; Elisabetta Meucci; Cecilia Zuppi; Federica Vincenzoni; Bruno Giardina; Massimo Castagnola; Irene Messana
Journal:  Biochem Biophys Res Commun       Date:  2002-06-21       Impact factor: 3.575

Review 10.  Oxygen-sensitive membrane transporters in vertebrate red cells.

Authors:  J S Gibson; A R Cossins; J C Ellory
Journal:  J Exp Biol       Date:  2000-05       Impact factor: 3.312

View more
  29 in total

1.  Rational modification of vanillin derivatives to stereospecifically destabilize sickle hemoglobin polymer formation.

Authors:  Tanvi M Deshpande; Piyusha P Pagare; Mohini S Ghatge; Qiukan Chen; Faik N Musayev; Jurgen Venitz; Yan Zhang; Osheiza Abdulmalik; Martin K Safo
Journal:  Acta Crystallogr D Struct Biol       Date:  2018-10-02       Impact factor: 7.652

2.  Metabolomics of ADSOL (AS-1) red blood cell storage.

Authors:  John D Roback; Cassandra D Josephson; Edmund K Waller; James L Newman; Sulaiman Karatela; Karan Uppal; Dean P Jones; James C Zimring; Larry J Dumont
Journal:  Transfus Med Rev       Date:  2014-02-05

3.  FT-4202, an oral PKR activator, has potent antisickling effects and improves RBC survival and Hb levels in SCA mice.

Authors:  Archana Shrestha; Mengna Chi; Kimberly Wagner; Astha Malik; Jennifer Korpik; Adam Drake; Keertik Fulzele; Sylvie Guichard; Punam Malik
Journal:  Blood Adv       Date:  2021-05-11

4.  Elevated ecto-5'-nucleotidase: a missing pathogenic factor and new therapeutic target for sickle cell disease.

Authors:  Hong Liu; Morayo Adebiyi; Rong Rong Liu; Anren Song; Jeanne Manalo; Yuan Edward Wen; Alexander Q Wen; Tingting Weng; Junsuk Ko; Modupe Idowu; Rodney E Kellems; Holger K Eltzschig; Michael R Blackburn; Harinder S Juneja; Yang Xia
Journal:  Blood Adv       Date:  2018-08-14

5.  Curative vs targeted therapy for SCD: does it make more sense to address the root cause than target downstream events?

Authors:  Marilyn J Telen
Journal:  Blood Adv       Date:  2020-07-28

Review 6.  Therapeutic strategies to alter the oxygen affinity of sickle hemoglobin.

Authors:  Martin K Safo; Gregory J Kato
Journal:  Hematol Oncol Clin North Am       Date:  2014-01-21       Impact factor: 3.722

7.  Design, Synthesis, and Biological Evaluation of Ester and Ether Derivatives of Antisickling Agent 5-HMF for the Treatment of Sickle Cell Disease.

Authors:  Guoyan G Xu; Piyusha P Pagare; Mohini S Ghatge; Ronni P Safo; Aheema Gazi; Qiukan Chen; Tanya David; Alhumaidi B Alabbas; Faik N Musayev; Jürgen Venitz; Yan Zhang; Martin K Safo; Osheiza Abdulmalik
Journal:  Mol Pharm       Date:  2017-09-13       Impact factor: 4.939

Review 8.  New developments in anti-sickling agents: can drugs directly prevent the polymerization of sickle haemoglobin in vivo?

Authors:  Esther Oder; Martin K Safo; Osheiza Abdulmalik; Gregory J Kato
Journal:  Br J Haematol       Date:  2016-09-08       Impact factor: 6.998

9.  Environmental tobacco smoke and airway obstruction in children with sickle cell anemia.

Authors:  Robyn T Cohen; Robert C Strunk; Joshua J Field; Carol L Rosen; Fenella J Kirkham; Susan Redline; Janet Stocks; Mark J Rodeghier; Michael R DeBaun
Journal:  Chest       Date:  2013-10       Impact factor: 9.410

10.  The CYB5R3c .350C>G and G6PD A alleles modify severity of anemia in malaria and sickle cell disease.

Authors:  Victor R Gordeuk; Binal N Shah; Xu Zhang; Philip E Thuma; Stenford Zulu; Rodgers Moono; N Scott Reading; Jihyun Song; Yingze Zhang; Mehdi Nouraie; Andrew Campbell; Caterina P Minniti; Sohail R Rana; Deepika S Darbari; Gregory J Kato; Mei Niu; Oswaldo L Castro; Roberto Machado; Mark T Gladwin; Josef T Prchal
Journal:  Am J Hematol       Date:  2020-09-23       Impact factor: 10.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.